At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Topical Brimonidine Reduces IPL-induced Erythema Without Affecting Efficacy: a Randomized Controlled Trial in Patients With Facial Telangiectasias
In Brief
A Phase 4 clinical trial evaluating Brimonidine and IPL+air-cooling for Telangiectasias. Completed, enrolled 19 participants across 1 site.
Detailed Summary
The aim of the study is to investigate whether brimonidine cream can reduce IPL-induced inflammation in terms of redness, swelling and pain in patients with facial vascular lesions (telangiectasias). Furthermore, the effect of brimonidine cream on IPL-efficacy is evaluated one month after final IPL-treatment. The hypothesis is that brimonidine, which has been proved effective in reduction of symptomatic erythema in patients with rosacea, also may have the ability to reduce IPL-induced erythema. Since the potential reduction in erythema is caused by vasoconstriction, brimonidine may further reduce IPL-induced oedema and pain.
Study Details
Timeline
Interventions
Patients receive brimonidine to half of their face, whereas the other half receives no treatment and thereby patients are their own control
IPL+air-cooling are applied to the whole face and the control side thereby only receives IPL+air-cooling